Relative effects of weight loss and dietary fat modification on serum lipid levels in the dietary treatment of obesity. 1993

R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
Department of Human Nutrition, Wageningen Agricultural University, The Netherlands.

The independent effects of weight loss and dietary fat modification on serum lipids were investigated in two groups of healthy moderately obese men and women. In one group (sequential group, n = 19), a weight-stable low-fat, low-saturated-fat diet (Low-Sat) was given for 7 weeks (= dietary modification), followed by a 4.2 MJ/day deficit Low-Sat diet for 13 weeks (i.e., weight loss alone). Another group (simultaneous group, n = 22) received a 4.2 MJ/day deficit Low-Sat diet for 13 weeks (i.e., weight loss+dietary fat modification). Each group was subject to an initial weight-stable high-fat, high-saturated fat diet for 3 weeks and a final weight stable Low-Sat diet for 3 weeks. Both groups lost similar amounts of body weight, about 13 kg, and had similar overall changes in total cholesterol, low density lipoprotein (LDL), cholesterol, high density lipoprotein (HDL) cholesterol, the HDL/LDL ratio, and triglycerides. Analysis of the separate effects of the Low-Sat diet without energy restriction and of weight loss in the sequential group showed that weight loss per se was responsible for about 50% of the total reduction in total cholesterol, and for about 60% and 70% of the fall in LDL cholesterol and triglycerides, respectively. Fat modification without weight loss reduced HDL cholesterol by 11.1% and the HDL/LDL ratio by 7.7%, while weight loss per se led to increases in HDL cholesterol of 12.5% and in the HDL/LDL ratio of 24.0%. We conclude that the effects of reduction in fat and saturated fat intake and weight loss are additive.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
August 2001, Obesity research,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
January 2010, The American journal of Chinese medicine,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
January 1987, International journal of obesity,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
August 1964, The Journal of clinical investigation,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
July 1966, British medical journal,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
April 2003, JAMA,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
January 2022, Journal of oleo science,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
January 2016, Journal of food & nutritional disorders,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
January 2001, The Journal of clinical psychiatry,
R Leenen, and K van der Kooy, and S Meyboom, and J C Seidell, and P Deurenberg, and J A Weststrate
April 1999, Diabetes,
Copied contents to your clipboard!